Showing results (151-160 of 212) with videos related to
Sort By:
Pageof 22
Cancer Prevention Research (Philadelphia, Pa.)|August 16, 2015
Physical Activity and Prostate Tumor Vessel Morphology: Data from the Health Professionals Follow-up StudyErin L Van Blarigan, John P Gerstenberger, Stacey A Kenfield, et al.Current Developments in Nutrition|October 13, 2025
Targeted Urinary Profiling as a Biomarker of Dietary Flavonoid Intake from Fruits and Vegetables and its Relationship to the Timing of Dietary AssessmentEmily B Hill, Anna Pashkova, Elizabeth M Grainger, et al.Integrative Cancer Therapies|December 17, 2019
Effects of a Group-Mediated Cognitive Behavioral Lifestyle Intervention on Select Social Cognitive Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation TherapyBrian C Focht, Alexander R Lucas, Elizabeth Grainger, et al.Cancer Prevention Research (Philadelphia, Pa.)|April 28, 2019
Vitamin D Signaling Suppresses Early Prostate Carcinogenesis in TgAPT<sub>121</sub> MiceJames C Fleet, Pavlo L Kovalenko, Yan Li, et al.Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Randomized dose-response trial of n-3 fatty acids in hormone receptor negative breast cancer survivors- impact on breast adipose oxylipin and DNA methylation patternsDavid E Frankhouser, Todd DeWess, Isabel F Snodgrass, et al.Clinical Proteomics|September 1, 2015
Proteomic profiling identifies specific histone species associated with leukemic and cancer cellsRajbir Singh, Sean W Harshman, Amy S Ruppert, et al.The American Journal of Clinical Nutrition|April 27, 2025
Randomized dose-response trial of n-3 fatty acids in hormone receptor negative breast cancer survivors - impact on breast adipose oxylipin and DNA methylation patternsDavid E Frankhouser, Todd DeWees, Isabel F Snodgrass, et al.Cancer|November 20, 2020
Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low-molecular-weight heparinSandip H Patel, Tiffany L George, Tzu-Fei Wang, et al.Biorxiv : the Preprint Server for Biology|November 28, 2023
The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERβ and AR using a novel ERβ-selective ligand alongside EnzalutamideJaimie S Gray, Sajad A Wani, Shahid Hussain, et al.Cancers|February 24, 2024
Roles of Androgen Receptor Signaling in Urothelial CarcinomaDebasish Sundi, Katharine A Collier, Yuanquan Yang, et al.Pageof 22